K
53
2
T
50
3
DLTR
34
-4
CVS
48
3
USB
50
2
AMGN
44
5
MS
74
-2
PRU
57
-3
HON
65
-2
HD
47
-5
PCG
93
2
BA
52
2
FOXA
55
9
FMC
31
5
HSIC
54
-3
APA
21
2
MRK
22
3
EQR
54
-2
CSX
51
-2
EXC
54
-2
K
53
2
T
50
3
DLTR
34
-4
CVS
48
3
USB
50
2
AMGN
44
5
MS
74
-2
PRU
57
-3
HON
65
-2
HD
47
-5
PCG
93
2
BA
52
2
FOXA
55
9
FMC
31
5
HSIC
54
-3
APA
21
2
MRK
22
3
EQR
54
-2
CSX
51
-2
EXC
54
-2
Financhill
Back

Gilead Sciences 10K Form

Sell
47

GILD
Gilead Sciences

Last Price:
88.62
Seasonality Move:
7.4%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-08 10Q GILD/Gilead Sciences Quarterly
2024-02-23 10K GILD/Gilead Sciences Annual
2023-11-07 10Q GILD/Gilead Sciences Quarterly
2023-08-04 10Q GILD/Gilead Sciences Quarterly
2023-05-03 10Q GILD/Gilead Sciences Quarterly
2023-02-22 10K GILD/Gilead Sciences Annual

Receive GILD News And Ratings

See the #1 stock for the next 7 days that we like better than GILD

GILD Financial Statistics

Sales & Book Value

Annual Sales: $27.12B
Cash Flow: $4.17B
Price / Cash Flow: 11.74
Annual Sales: $14.83
Price / Book: 5.97

Profitability

EPS (TTM): 0.09000
Net Income (TTM): $126M
Gross Margin: $20.62B
Return on Equity: 0.64%
Return on Assets: 0.22%

Gilead Sciences Earnings Forecast

Key Gilead Sciences Financial Ratios

  • The Gross Profit Margin over the past 33 years for GILD is 76.04%.
  • The Selling, General & Administrative Expenses for GILD have been equal to 22.46% of Gross Profit Margin.
  • The Research & Development expenses have been 21.09% of Revenue.
  • The Interest Expense is 16.66% of Operating Income.
  • The Net Earning history of GILD is 20.89% of Total Revenues.
  • Per Share Earnings over the last 33 years have been positive in 19 years.

Gilead Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Biotechnology
Sector: Health Care
Current Symbol: GILD
CUSIP: 375558
Website: gilead.com

Debt

Debt-to-Equity Ratio: 1.26
Current Ratio: 1.26
Quick Ratio: 0.82

Price-to-Earnings

Trailing P/E Ratio: 19.66
Forward P/E Ratio: 11.83

GILD Technical Analysis vs Fundamental Analysis

Sell
47
Gilead Sciences (GILD) is a Sell

Is Gilead Sciences a Buy or a Sell?

  • Gilead Sciences stock is rated a Sell
    The current Gilead Sciences [GILD] share price is $88.63. The Score for GILD is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.